SVA [SINOVAC BIOTECH] 6-K: Sinovac Wins Beijing Public Health Bureau’s Bid to

[Sinovac Wins Beijing Public Health Bureau's Bid to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens BEIJING, Aug. 28 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the Beijing Public Health Bureau has selected Sinovac as one of the four manufacturers to supply Anflu(R), Sinovac's seasonal influenza vaccine, for the] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]

By | 2016-03-24T04:43:09+00:00 September 28th, 2009|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

THTI [THT Heat Transfer Technology] 8-K: (Original Filing)

[THT HEAT TRANSFER TECHNOLOGY, INC. Agreement Company Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required of] [2 THT HEAT TRANSFER TECHNOLOGY, INC. Agreement Company Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required] [THT HEAT TRANSFER TECHNOLOGY, INC. Agreement Company Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required of] [INDEMNIFICATION AGREEMENT Agreement Company Indemnitee This Indemnification Agreement (this “ RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Company’s officers and directors with adequate and reliable advance knowledge or guidance with respect to the legal risks and potential liabilities to which they may become personally exposed as] [INDEMNIFICATION AGREEMENT Agreement Company Indemnitee This Indemnification Agreement (this “ RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Company’s officers and directors with adequate and reliable advance knowledge or guidance with respect to the legal risks and potential liabilities to which they may become personally exposed as] [INDEMNIFICATION AGREEMENT Agreement Company Indemnitee This Indemnification Agreement (this “ RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Company’s officers and directors with adequate and reliable advance knowledge or guidance with respect to the legal risks and potential liabilities to which they may become personally exposed as] [BTHC VIII, INC. I. Objectives Company BTHC VIII, Inc. and its subsidiaries (together, the “ Code Covered Persons This Code of Ethics (“ honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships; Commission compliance with applicable governmental laws, rules and regulations; the prompt internal reporting to an appropriate person] [BTHC VIII, INC. AUDIT COMMITTEE CHARTER The Purpose of the Audit Committee The Audit Committee members are not professional accountants or auditors and their functions are not intended to duplicate or to certify the activities of management and the independent auditor. Consequently, it is not the duty of the Audit Committee to conduct audits or to determine that the Company’s] [BTHC VIII, INC. The Purpose of the Compensation Committee The purpose of the Compensation Committee of BTHC VIII, Inc. (the “Company”) is to discharge the responsibilities of the Company’s Board of Directors relating to compensation of the Company’s executives, to produce an annual report on executive compensation for inclusion in the Company’s proxy statement, and to oversee and advise the] [BTHC VIII, INC. The Purpose of the Governance and Nominating Committee The purpose of the Governance and Nominating Committee of BTHC VIII, Inc. (the "Company"), is to determine the slate of director nominees for election to the Company’s Board of Directors, to identify and recommend candidates to fill vacancies occurring between annual stockholder meetings, to review, evaluate and recommend changes] [FORM 8-K CURRENT REPORT September 28, 2009 (September 25, 2009) Date of report (Date of earliest event reported): BTHC VIII, INC. Delaware 000-52232 20-5463509 (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) THT Industrial Park, No.5 Nanhuan Road, Tiexi District Siping, Jilin Province 136000 People’s Republic of China 86-434-3265241 N/A (Former name or former address, if]

By | 2016-03-22T21:43:28+00:00 September 28th, 2009|Categories: Chinese Stocks, SEC Original, THTI|Tags: , , , , , |0 Comments

THTI [THT Heat Transfer Technology] 8-K: THT HEAT TRANSFER TECHNOLOGY, INC. Agreement Company Director

[THT HEAT TRANSFER TECHNOLOGY, INC. Agreement Company Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required of] [2 THT HEAT TRANSFER TECHNOLOGY, INC. Agreement Company Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required] [THT HEAT TRANSFER TECHNOLOGY, INC. Agreement Company Director THIS AGREEMENT (The “ BACKGROUND The Board of Directors of the Company desires to appoint the Director to fill an existing vacancy and to have the Director perform the duties of an independent director and the Director desires to be so appointed for such position and to perform the duties required of] [INDEMNIFICATION AGREEMENT Agreement Company Indemnitee This Indemnification Agreement (this “ RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Company’s officers and directors with adequate and reliable advance knowledge or guidance with respect to the legal risks and potential liabilities to which they may become personally exposed as] [INDEMNIFICATION AGREEMENT Agreement Company Indemnitee This Indemnification Agreement (this “ RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Company’s officers and directors with adequate and reliable advance knowledge or guidance with respect to the legal risks and potential liabilities to which they may become personally exposed as] [INDEMNIFICATION AGREEMENT Agreement Company Indemnitee This Indemnification Agreement (this “ RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Company’s officers and directors with adequate and reliable advance knowledge or guidance with respect to the legal risks and potential liabilities to which they may become personally exposed as] [BTHC VIII, INC. I. Objectives Company BTHC VIII, Inc. and its subsidiaries (together, the “ Code Covered Persons This Code of Ethics (“ honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships; Commission compliance with applicable governmental laws, rules and regulations; the prompt internal reporting to an appropriate person] [BTHC VIII, INC. AUDIT COMMITTEE CHARTER The Purpose of the Audit Committee The Audit Committee members are not professional accountants or auditors and their functions are not intended to duplicate or to certify the activities of management and the independent auditor. Consequently, it is not the duty of the Audit Committee to conduct audits or to determine that the Company’s] [BTHC VIII, INC. The Purpose of the Compensation Committee The purpose of the Compensation Committee of BTHC VIII, Inc. (the “Company”) is to discharge the responsibilities of the Company’s Board of Directors relating to compensation of the Company’s executives, to produce an annual report on executive compensation for inclusion in the Company’s proxy statement, and to oversee and advise the] [BTHC VIII, INC. The Purpose of the Governance and Nominating Committee The purpose of the Governance and Nominating Committee of BTHC VIII, Inc. (the "Company"), is to determine the slate of director nominees for election to the Company’s Board of Directors, to identify and recommend candidates to fill vacancies occurring between annual stockholder meetings, to review, evaluate and recommend changes] [FORM 8-K CURRENT REPORT September 28, 2009 (September 25, 2009) Date of report (Date of earliest event reported): BTHC VIII, INC. Delaware 000-52232 20-5463509 (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) THT Industrial Park, No.5 Nanhuan Road, Tiexi District Siping, Jilin Province 136000 People’s Republic of China 86-434-3265241 N/A (Former name or former address, if]

By | 2016-03-22T21:45:17+00:00 September 28th, 2009|Categories: Chinese Stocks, THTI, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 424B3: FORM 8-K CURRENT REPORT August 28, 2009 China

[FORM 8-K CURRENT REPORT August 28, 2009 China Pharmas, ------------------------------ Delaware (State or other jurisdiction oforporation) 000-29532 73-1564807 (IRS Employer Identification Number) 2nd Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 86-898-66811730fe Harbor Statement under the Private Securities Litigation Reform Act of 1995 ITEM 8.01 Other Events]

By | 2016-02-08T00:08:07+00:00 September 28th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac to Present at 2009 UBS Global Life Sciences Conference BEIJING, Sept. 16 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that Mr. Weidong Yin, Chairman, President & CEO, will present at the 2009 UBS Global Life Sciences Conference in New York City. The presentation is scheduled for Tuesday, September 22,] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]

By | 2016-03-24T04:25:36+00:00 September 28th, 2009|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-A12B: (Original Filing)

[Explanatory Notempanymmon Stock Exchange Act This Registration Statement on Form 8-A is being filed by China Pharmas, a Delawarerporation (the Item 1.Description of thempanys Securities to be Registeredmmission 1 China Pharmas, I nc . Zhilin Li Chief Executive Officer 2 cph812b092809.htm 1 8-A12B]

By | 2016-02-08T00:09:05+00:00 September 28th, 2009|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac to Present at 2009 UBS Global Life

[Sinovac to Present at 2009 UBS Global Life Sciences Conference BEIJING, Sept. 16 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that Mr. Weidong Yin, Chairman, President & CEO, will present at the 2009 UBS Global Life Sciences Conference in New York City. The presentation is scheduled for Tuesday, September 22,] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]

By | 2016-03-24T04:27:58+00:00 September 28th, 2009|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 8-A12B: Explanatory Notempanymmon Stock Exchange Act This Registration Statement

[Explanatory Notempanymmon Stock Exchange Act This Registration Statement on Form 8-A is being filed by China Pharmas, a Delawarerporation (the Item 1.Description of thempanys Securities to be Registeredmmission 1 China Pharmas, I nc . Zhilin Li Chief Executive Officer 2 cph812b092809.htm 1 8-A12B]

By | 2016-02-08T00:09:56+00:00 September 28th, 2009|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine BEIJING, Sept. 8 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of vaccines in China, today announced that the first lot of PANFLU.1, its H1N1 vaccine, has passed the lot release process of China's National Institute for the Control of Pharmaceutical and Biological Products and] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]

By | 2016-03-24T04:28:52+00:00 September 28th, 2009|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Obtains Lot Release Certificate for Its First

[Sinovac Obtains Lot Release Certificate for Its First Batch of H1N1 Vaccine BEIJING, Sept. 8 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of vaccines in China, today announced that the first lot of PANFLU.1, its H1N1 vaccine, has passed the lot release process of China's National Institute for the Control of Pharmaceutical and Biological Products and] [FORM 6-K __________ __________ SINOVAC BIOTECH LTD. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F X Yes _______ No N/A 82- SINOVAC BIOTECH LTD. Form 6-K TABLE OF CONTENTS Page 3 4]

By | 2016-03-24T04:30:01+00:00 September 28th, 2009|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar